Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amnion Bilayer and Stem Cell Therapy for Thin Endometrium
NCT04676269Phase 1Unknown
- Sponsor
- Universitas Indonesia
- Start
- Dec 2019
- Primary completion
- Jul 2021
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human amniotic epithelial stem cells in infertility (4 arms), sponsored by Universitas Indonesia. Primary endpoints: Change in endometrium thickness at 14 days and Change in amenorrhea severity at 14 days. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04676269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04676269.